Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
doi: 10.1159/000070226 82 NowaczykMJMSiuVMKrakowiakPAPorterFD
Pfizer halted development of its oral GLP-1 danuglipron in 2025 after a trial participant developed liver injury, reflecting safety concerns that require ongoing monitoring with real-world data
Even as the concentration decreases in the reservoir, the rate of drug delivery stays the same, he said
Adrenergic receptor 1 stimulates Ca 2+ influx via activation of phospholipase C followed by increase in intracellular concentration of inositol triphosphate (IP 3 ) and diacylglycerol (DAG)
Glutathione S-transferase M null homozygosity and risk of systemic lupus erythematosus associated with sun exposure: a possible gene-environment interaction for autoimmunity
US$ 25.51
US$ 23.41
US$ 28.21
US$ 25.27
US$ 26.10
US$ 24.64
US$ 22.76
